Aisling Capital Management LP Syndax Pharmaceuticals Inc Transaction History
Aisling Capital Management LP
- $273 Million
- Q4 2024
A detailed history of Aisling Capital Management LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Aisling Capital Management LP holds 1,025,000 shares of SNDX stock, worth $16.8 Million. This represents 4.96% of its overall portfolio holdings.
Number of Shares
1,025,000
Previous 1,025,000
-0.0%
Holding current value
$16.8 Million
Previous $19.7 Million
31.33%
% of portfolio
4.96%
Previous 8.12%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
232Shares Held
96.9MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$140 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$130 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$97.5 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$87 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$80 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $927M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...